The Myelodysplastic Syndromes Channel is supported with funding from Geron (Silver).

VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

EHA 2022 | RBP dysregulation and bone marrow failure: implications for future research

Name: RBP dysregulation and bone marrow failure: implications for future research
Uploaded: 2022-06-20T00:00:00Z
Duration: 1 min 2 s
Description: Pedro Aguilar-Garrido, Spanish National Cancer Research Center (CNIO), Madrid, Spain, briefly explains how a better understanding of novel mechanisms behind bone marrow failure, such as RNA binding protein (RBP) dysregulation, may have wider implications in other disease areas. This press briefing was recorded at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Pedro Aguilar-Garrido • 20 Jun 2022

EHA 2022

General Myelodysplastic Syndromes

Pedro Aguilar-Garrido, Spanish National Cancer Research Center (CNIO), Madrid, Spain, briefly explains how a better understanding of novel mechanisms behind bone marrow failure, such as RNA binding protein (RBP) dysregulation, may have wider implications in other disease areas. This press briefing was recorded at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.